GLP1R and atrial fibrillation: Nonetheless, the positive molecular effects observed in preclinical studies suggest that GLP-1 RAs, particularly liraglutide and exenatide, may exert beneficial anti-fibrotic and metabolic effects that could be relevant in AF.